Personal Home Page

http://users.uoi.gr/hyepilab/people.php

Articles in Scholarly Journals [Incomplete List]

1. Large-Scale Analysis of Association Between LRP5 and LRP6 Variants and Osteoporosis
   JAMA: The Journal of the American Medical Association, vol. 299, no. 11, pp. 1277–1290, 2008
2. Percutaneous coronary intervention after myocardial infarction and the late open artery hypothesis
   American Heart Journal, vol. 155, no. 4, pp. e43–e43, 2008
3. Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone
   American Heart Journal, 2008
4. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: The GENOMOS study
   Bone, vol. 42, no. 5, pp. 969–981, 2008
5. Meta-analysis for ranked discovery datasets: Theoretical framework and empirical demonstration for microarrays
   Computational Biology and Chemistry, vol. 32, no. 1, pp. 39–47, 2008
6. Inflated numbers of authors over time have not been just due to increasing research complexity
   Journal of Clinical Epidemiology, vol. 61, no. 6, pp. 546–551, 2008
7. Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers
   Journal of Clinical Epidemiology, vol. 61, no. 5, pp. 464–470, 2008
8. Genome-wide association studies for complex traits: consensus, uncertainty and challenges
   Nature Reviews Genetics, vol. 9, no. 5, Article ID nrg2344, 13 pages, 2008
9. Required sample size and nonreplicability thresholds for heterogeneous genetic associations
   Proceedings of the National Academy of Sciences, vol. 105, no. 2, pp. 617–622, 2008
10. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
    Annals of the Rheumatic Diseases, vol. 67, no. 2, pp. 195–205, 2008
11. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups
    Heart, vol. 93, no. 4, pp. 450–455, 2007
12. Genetic and molecular epidemiology
    Journal of Epidemiology & Community Health, vol. 61, no. 9, pp. 757–758, 2007
13. Osteomyelitis: Antigranulocyte Scintigraphy with 99mTc Radiolabeled Monoclonal Antibodies for Diagnosis Meta-Analysis
    Radiology, vol. 245, no. 3, pp. 732–741, 2007
14. Genetic Predisposition to Asthma and Atopy (Despina G. Contopoulos−Ioannidis et al., Ioannina)
    Respiration, 2007
15. Non-Replication and Inconsistency in the Genome-Wide Association Setting
    Human Heredity, vol. 64, no. 4, pp. 203–213, 2007
16. Authors' response to V Johnson and Y Yuan
    Clinical Trials, vol. 4, no. 3, pp. 256–257, 2007
17. An exploratory test for an excess of significant findings
    Clinical Trials, vol. 4, no. 3, pp. 245–253, 2007
18. International ranking systems for universities and institutions: a critical appraisal
    BMC Medicine, vol. 5, no. 1, p. 30, 2007
19. Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis
    Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 8, pp. 3162–3170, 2007
20. Meta-Analysis of Genome-Wide Scans Provides Evidence for Sex- and Site-Specific Regulation of Bone Mass
    Journal of Bone and Mineral Research, vol. 22, no. 2, pp. 173–183, 2007
21. Selection in Reported Epidemiological Risks: An Empirical Assessment
    PLoS Medicine, vol. 4, no. 3, p. e79, 2007
22. Reporting of Systematic Reviews: The Challenge of Genetic Association Studies
    PLoS Medicine, vol. 4, no. 6, p. e211, 2007
23. Why Most Published Research Findings Are False: Author's Reply to Goodman and Greenland
    PLoS Medicine, vol. 4, no. 6, p. e215, 2007
24. Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations
    PLoS ONE, vol. 2, no. 9, p. e841, 2007
25. Genetic Effects versus Bias for Candidate Polymorphisms in Myocardial Infarction: Case Study and Overview of Large-Scale Evidence
    American Journal of Epidemiology, vol. 165, no. 9, pp. 973–984, 2007
26. Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association
    American Journal of Epidemiology, vol. 166, no. 8, pp. 863–866, 2007
27. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies
    International Journal of Epidemiology, vol. 36, no. 2, pp. 439–445, 2007
28. Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials
    International Journal of Epidemiology, vol. 36, no. 2, pp. 422–430, 2007
29. Assessment of cumulative evidence on genetic associations: interim guidelines
    International Journal of Epidemiology, vol. 37, no. 1, pp. 120–132, 2007
30. The Emergence of Networks in Human Genome Epidemiology
    Epidemiology, vol. 18, no. 1, pp. 1–8, 2007
31. Quality of Reporting of Cancer Prognostic Marker Studies: Association With Reported Prognostic Effect
    JNCI Journal of the National Cancer Institute, vol. 99, no. 3, pp. 236–243, 2007
32. Molecular evidence-based medicine.
    European Journal of Clinical Investigation, vol. 37, no. 5, pp. 340–349, 2007
33. PCI for Stable Coronary Disease
    New England Journal of Medicine, vol. 357, no. 4, pp. 414–418, 2007
34. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
    The Lancet Oncology, vol. 8, no. 10, pp. 898–911, 2007
35. Effects of different chemotherapy regimens on survival for advanced cervical cancer: Systematic review and meta-analysis
    Cancer Treatment Reviews, vol. 33, no. 1, pp. 24–38, 2007
36. Selective discussion and transparency in microarray research findings for cancer outcomes
    European Journal of Cancer, vol. 43, no. 13, pp. 1999–2010, 2007
37. Almost all articles on cancer prognostic markers report statistically significant results
    European Journal of Cancer, 2007
38. Limitations are not properly acknowledged in the scientific literature
    Journal of Clinical Epidemiology, vol. 60, no. 4, pp. 324–329, 2007
39. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls
    Human Genetics, vol. 123, no. 1, pp. 1–14, 2007
40. Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients
    American Heart Journal, vol. 154, no. 6, pp. 1065–1071, 2007
41. Meta-Analysis of Fractional Flow Reserve Versus Quantitative Coronary Angiography and Noninvasive Imaging for Evaluation of Myocardial Ischemia
    The American Journal of Cardiology, vol. 99, no. 4, pp. 450–456, 2007
42. Impact of Schizophrenia Candidate Genes on Schizotypy and Cognitive Endophenotypes at the Population Level
    Biological Psychiatry, vol. 62, no. 7, pp. 784–792, 2007
43. Persistence of Contradicted Claims in the Literature
    JAMA: The Journal of the American Medical Association, vol. 298, no. 21, pp. 2517–2526, 2007
44. Claims of Sex Differences: An Empirical Assessment in Genetic Associations
    JAMA: The Journal of the American Medical Association, vol. 298, no. 8, pp. 880–893, 2007
45. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey
    Canadian Medical Association Journal, vol. 176, no. 8, pp. 1091–1096, 2007
46. Is Molecular Profiling Ready for Use in Clinical Decision Making?
    The Oncologist, vol. 12, no. 3, pp. 301–311, 2007
47. Pharmacogenetics of the response to ?2 agonist drugs: a systematic overview of the field
    Pharmacogenomics, vol. 8, no. 8, pp. 933–958, 2007
48. Not-so-surprising findings
    Canadian Medical Association Journal, vol. 175, no. 2, pp. 172–172, 2006
49. Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study
    PLoS Medicine, vol. 3, no. 4, p. e90, 2006
50. Correction: Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study
    PLoS Medicine, vol. 3, no. 5, p. e223, 2006
51. Patient Outcomes with Teaching Versus Nonteaching Healthcare: A Systematic Review
    PLoS Medicine, vol. 3, no. 9, p. e341, 2006
52. Bayesian meta-analysis and meta-regression for gene–disease associations and deviations from Hardy–Weinberg equilibrium
    Statistics in Medicine, vol. 26, no. 3, pp. 553–567, 2006
53. Collaborative Analysis of  -Synuclein Gene Promoter Variability and Parkinson Disease
    JAMA: The Journal of the American Medical Association, vol. 296, no. 6, pp. 661–670, 2006
54. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: A meta-analysis
    Bone, vol. 39, no. 4, pp. 938–945, 2006
55. Heterogeneity-based genome search meta-analysis for preeclampsia
    Human Genetics, vol. 120, no. 3, pp. 360–370, 2006
56. Self-Reported Health in High and Very High Incomes
    Quality of Life Research, vol. 15, no. 3, pp. 547–558, 2006
57. Extreme between-study homogeneity in meta-analyses could offer useful insights
    Journal of Clinical Epidemiology, vol. 59, no. 10, pp. 1023–1032, 2006
58. Reply
    Journal of Allergy and Clinical Immunology, vol. 117, no. 1, pp. 222–223, 2006
59. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: An overview of survival data
    European Journal of Cancer, vol. 42, no. 3, pp. 319–326, 2006
60. Origin authentication in interdomain routing
    Computer Networks, vol. 50, no. 16, pp. 2953–2980, 2006
61. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study
    The Lancet Neurology, vol. 5, no. 11, pp. 917–923, 2006
62. Gene expression profiling for individualized breast cancer chemotherapy: success or not?
    Nature Clinical Practice Oncology, vol. 3, no. 10, Article ID ncponc0631, 1 pages, 2006
63. A road map for efficient and reliable human genome epidemiology
    Nature Genetics, vol. 38, no. 1, Article ID ng0106-3, 2 pages, 2006
64. Indirect comparisons: the mesh and mess of clinical trials
    The Lancet, vol. 368, no. 9546, pp. 1470–1472, 2006
65. An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment
    Pharmacogenetics and Genomics, vol. 16, no. 10, pp. 705–711, 2006
66. Concordance of functional in vitro data and epidemiological associations in complex disease genetics
    Genetics in Medicine, vol. 8, no. 9, pp. 583–593, 2006
67. Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis
    CancerSpectrum Knowledge Environment, vol. 98, no. 18, pp. 1285–1291, 2006
68. Common Genetic Variants for Breast Cancer: 32 Largely Refuted Candidates and Larger Prospects
    CancerSpectrum Knowledge Environment, vol. 98, no. 19, pp. 1350–1353, 2006
69. Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments
    CancerSpectrum Knowledge Environment, vol. 98, no. 22, pp. 1655–1663, 2006
70. Implications of Small Effect Sizes of Individual Genetic Variants on the Design and Interpretation of Genetic Association Studies of Complex Diseases
    American Journal of Epidemiology, vol. 164, no. 7, pp. 609–614, 2006
71. Commentary: Grading the credibility of molecular evidence for complex diseases
    International Journal of Epidemiology, vol. 35, no. 3, pp. 572–578, 2006
72. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
    Canadian Medical Association Journal, vol. 174, no. 5, pp. 635–641, 2006
73. Family-Based versus Unrelated Case-Control Designs for Genetic Associations
    PLoS Genetics, vol. 2, no. 8, p. e123, 2006
74. Expanded Publishing Model for Genetic Association Studies
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 1, pp. 185–185, 2006
75. Journals Should Publish All "Null" Results and Should Sparingly Publish "Positive" Results
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 1, pp. 186–186, 2006
76. Origin and funding of the most frequently cited papers in medicine: database analysis
    BMJ, vol. 332, no. 7549, pp. 1061–1064, 2006
77. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study
    BMJ, vol. 333, no. 7561, pp. 224–0, 2006
78. The importance of independent risk-factors for long-term mortality prediction after cardiac surgery
    European Journal of Clinical Investigation, vol. 36, no. 9, pp. 599–607, 2006
79. Prosthesis Infection: Diagnosis after Total Joint Arthroplasty with Antigranulocyte Scintigraphy with 99mTc-labeled Monoclonal Antibodies--A Meta-Analysis
    Radiology, vol. 242, no. 1, pp. 101–108, 2006
80. Anemia treatment and decline of renal function
    Kidney International, vol. 67, no. 2, pp. 779–779, 2005
81. Why Most Published Research Findings Are False
    PLoS Medicine, vol. 2, no. 8, p. e124, 2005
82. Local Literature Bias in Genetic Epidemiology: An Empirical Evaluation of the Chinese Literature
    PLoS Medicine, vol. 2, no. 12, p. e334, 2005
83. Truth, Probability, and Frameworks
    PLoS Medicine, vol. 2, no. 11, p. e361, 2005
84. Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
    Clinical Cancer Research, vol. 11, no. 4, pp. 1434–1440, 2005
85. Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis
    Circulation, vol. 111, no. 22, pp. 2906–2912, 2005
86. HEGESMA: genome search meta-analysis and heterogeneity testing
    Bioinformatics, vol. 21, no. 18, pp. 3672–3673, 2005
87. Susceptibility to HIV Infection--Disentangling Host Genetics and Host Behavior
    The Journal of Infectious Diseases, vol. 193, no. 1, pp. 4–6, 2005
88. Microarrays and molecular research: noise discovery?
    The Lancet, vol. 365, no. 9458, pp. 454–455, 2005
89. CTLA-4 Gene Polymorphisms and Susceptibility to Type 1 Diabetes Mellitus: A HuGE Review and Meta-Analysis
    American Journal of Epidemiology, vol. 162, no. 1, pp. 3–16, 2005
90. A Network of Investigator Networks in Human Genome Epidemiology
    American Journal of Epidemiology, vol. 162, no. 4, pp. 302–304, 2005
91. Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations
    American Journal of Epidemiology, vol. 163, no. 4, pp. 300–309, 2005
92. Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
    CancerSpectrum Knowledge Environment, vol. 97, no. 3, pp. 188–194, 2005
93. Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
    CancerSpectrum Knowledge Environment, vol. 97, no. 11, pp. 858–858, 2005
94. Selective Reporting Biases in Cancer Prognostic Factor Studies
    CancerSpectrum Knowledge Environment, vol. 97, no. 14, pp. 1043–1055, 2005
95. Unavailability of online supplementary scientific information from articles published in major journals
    The FASEB Journal, vol. 19, no. 14, pp. 1943–1944, 2005
96. Extended-Interval Aminoglycoside Administration for Children: A Meta-Analysis
    The Journal of Urology, vol. 173, no. 4, pp. 1192–1192, 2005
97. CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis
    Pharmacogenetics and Genomics, vol. 15, no. 3, pp. 151–158, 2005
98. Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power
    European Journal of Human Genetics, vol. 13, no. 7, Article ID 5201410, 8 pages, 2005
99. A heterogeneity-based genome search meta-analysis for autism-spectrum disorders
    Molecular Psychiatry, vol. 11, no. 1, Article ID 4001750, 7 pages, 2005
100. Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction
     Journal of Thoracic and Cardiovascular Surgery, vol. 129, no. 2, pp. 314–321, 2005
101. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgeryThe Statins for Risk Reduction in Surgery (StaRRS) study
     Journal of the American College of Cardiology, vol. 45, no. 3, pp. 336–342, 2005
102. Meta-analysis of the association of β2-adrenergic receptor polymorphisms with asthma phenotypes
     Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 963–972, 2005
103. Multivariate models of self-reported health often neglected essential candidate determinants and methodological issues
     Journal of Clinical Epidemiology, vol. 58, no. 5, pp. 436–443, 2005
104. Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials
     Journal of Clinical Epidemiology, vol. 58, no. 6, pp. 543–549, 2005
105. Molecular Bias
     European Journal of Epidemiology, vol. 20, no. 9, pp. 739–745, 2005
106. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers
     American Journal of Obstetrics and Gynecology, vol. 192, no. 1, pp. 89–95, 2005
107. Meta-analysis comparing drug-eluting stents with bare metal stents
     The American Journal of Cardiology, vol. 95, no. 5, pp. 640–643, 2005
108. Mortality in systemic sclerosis: An international meta-analysis of individual patient data
     The American Journal of Medicine, vol. 118, no. 1, pp. 2–10, 2005
109. Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta-analysis
     Arthritis & Rheumatism, vol. 54, no. 1, pp. 312–324, 2005
110. Heterogeneity testing in meta-analysis of genome searches
     Genetic Epidemiology, vol. 28, no. 2, pp. 123–137, 2005
111. Relative Citation Impact of Various Study Designs in the Health Sciences
     JAMA: The Journal of the American Medical Association, vol. 293, no. 19, pp. 2362–2366, 2005
112. Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
     JAMA: The Journal of the American Medical Association, vol. 294, no. 2, pp. 218–228, 2005
113. Contradictions in Highly Cited Clinical Research
     JAMA: The Journal of the American Medical Association, vol. 294, no. 21, pp. 2695–2695, 2005
114. Extended-Interval Aminoglycosides in Children: More Guidance Is Needed: In Reply
     PEDIATRICS, vol. 115, no. 3, pp. 828–828, 2005
115. Comparison of Large Versus Smaller Randomized Trials for Mental Health-Related Interventions
     American Journal of Psychiatry, vol. 162, no. 3, pp. 578–584, 2005
116. Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes
     JAMA: The Journal of the American Medical Association, vol. 292, no. 17, pp. 2105–2114, 2004
117. Clinical Trials in Sub-Saharan Africa and Established Standards of Care: A Systematic Review of HIV, Tuberculosis, and Malaria Trials
     JAMA: The Journal of the American Medical Association, vol. 292, no. 2, pp. 237–242, 2004
118. UCHL1 is a Parkinson's disease susceptibility gene
     Annals of Neurology, vol. 55, no. 4, pp. 512–521, 2004
119. Correction
     Annals of Neurology, vol. 55, no. 6, pp. 899–899, 2004
120. Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis
     Human Genetics, vol. 116, no. 3, pp. 192–199, 2004
121. The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases
     Biomedecine & Pharmacotherapy, vol. 58, no. 5, pp. 286–291, 2004
122. Availability of large-scale evidence on specific harms from systematic reviews of randomized trials
     The American Journal of Medicine, vol. 117, no. 8, pp. 582–589, 2004
123. Treatment options for acute sinusitis in children
     Current Allergy and Asthma Reports, vol. 4, no. 6, pp. 471–477, 2004
124. The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies
     Journal of Clinical Epidemiology, vol. 57, no. 4, pp. 341–348, 2004
125. Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time
     Journal of Clinical Epidemiology, vol. 57, no. 11, pp. 1124–1130, 2004
126. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: A meta-analysis of randomized trials
     International Journal of Radiation OncologyBiologyPhysics, vol. 60, no. 3, pp. 888–895, 2004
127. Journal of the American College of Cardiology, vol. 44, no. 9, pp. 1867–1876, 2004
128. 'Racial' differences in genetic effects for complex diseases
     Nature Genetics, vol. 36, no. 12, Article ID ng1474, 6 pages, 2004
129. Establishment of genetic associations for complex diseases is independent of early study findings
     European Journal of Human Genetics, vol. 12, no. 9, Article ID 5201227, 7 pages, 2004
130. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial
     Kidney International, vol. 66, no. 2, Article ID 4494661, 7 pages, 2004
131. Evidence Report on the Treatment of Pain in Cancer Patients
     Journal of the National Cancer Institute Monographs, vol. 2004, no. 32, pp. 23–31, 2004
132. Global estimates of high-level brain drain and deficit
     The FASEB Journal, vol. 18, no. 9, pp. 936–939, 2004
133. Maternal viral load and rate of disease progression among vertically HIV-1-infected children
     AIDS, vol. 18, no. 1, pp. 99–108, 2004
134. Limited benefit of antiretroviral resistance testing in treatment-experienced patients
     AIDS, vol. 18, no. 16, pp. 2153–2161, 2004
135. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia
     Journal of Hypertension, vol. 22, no. 9, pp. 1655–1662, 2004
136. Meta-Analysis of the Association of the Cathepsin D Ala224Val Gene Polymorphism with the Risk of Alzheimer's Disease: A HuGE Gene-Disease Association Review
     American Journal of Epidemiology, vol. 159, no. 6, pp. 527–536, 2004
137. Safety Reporting in Randomized Trials of Mental Health Interventions
     American Journal of Psychiatry, vol. 161, no. 9, pp. 1692–1697, 2004
138. Diagnosis of Sensorineural Hearing Loss with Neural Networks versus Logistic Regression Modeling of Distortion Product Otoacoustic Emissions
     Audiology and Neuro-Otology, vol. 9, no. 2, pp. 81–87, 2004
139. Journal of Translational Medicine, vol. 2, no. 1, p. 5, 2004
140. Differential Effects of NOD2 Variants on Crohn's Disease Risk and Phenotype in Diverse Populations: A Metaanalysis
     The American Journal of Gastroenterology, vol. 99, no. 12, pp. 2393–2404, 2004
141. Large scale evidence and replication: insights from rheumatology and beyond
     Annals of the Rheumatic Diseases, vol. 64, no. 3, pp. 345–346, 2004
142. The Decameron of poor research
     BMJ, vol. 329, no. 7480, pp. 1436–1440, 2004
143. Just fast keying
     ACM Transactions on Information and System Security, vol. 7, no. 2, pp. 242–273, 2004
144. A key recovery attack on the 802.11b wired equivalent privacy protocol (WEP)
     ACM Transactions on Information and System Security, vol. 7, no. 2, pp. 319–332, 2004
145. Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma: A Meta-Analysis
     Clinical Cancer Research, vol. 10, no. 18, pp. 6208–6214, 2004
146. Evaluation of Cluster Randomized Controlled Trials in Sub-Saharan Africa
     American Journal of Epidemiology, vol. 158, no. 9, pp. 921–926, 2003
147. Mother-to-child transmission of HIV: developing integration of healthcare programmes with clinical, social and basic research studies
     Acta Paediatrica, vol. 92, no. 11, pp. 1343–1348, 2003
148. Modelling of escalating outpatient antibiotic expenditures
     Journal of Antimicrobial Chemotherapy, vol. 52, no. 6, pp. 1001–1004, 2003
149. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention
     Journal of the American College of Cardiology, vol. 42, no. 8, pp. 1406–1411, 2003
150. Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer biases and evolution over time
     European Journal of Cancer, vol. 39, no. 16, pp. 2278–2287, 2003
151. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis
     American Journal of Obstetrics and Gynecology, vol. 189, no. 5, pp. 1330–1335, 2003
152. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment
     The Lancet, vol. 362, no. 9394, pp. 1439–1444, 2003